Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers.
Häberle L, Erber R, Gass P, Hein A, Niklos M, Volz B, Hack CC, Schulz-Wendtland R, Huebner H, Goossens C, Christgen M, Dörk T, Park-Simon TW, Schneeweiss A, Untch M, Nekljudova V, Loibl S, Hartmann A, Beckmann MW, Fasching PA.
Häberle L, et al. Among authors: hein a.
Breast Cancer Res. 2025 Jan 24;27(1):13. doi: 10.1186/s13058-025-01960-8.
Breast Cancer Res. 2025.
PMID: 39856787
Free article.